Mucormycosis—A Possible Trigger Pathogen for Encapsulating Peritoneal Sclerosis

Abstract

Get full access to this article

View all access options for this article.

References

Kawaguchi

, Kawanishi

, Mujais

, Topley

, Oreopoulos

D.G.

Encapsulating sclerosing peritonitis: definition, etiology, diagnosis and treatment.

Perit Dial Int 2000; 20(Suppl 4): S43–55.

Nakamoto

Encapsulating sclerosing peritonitis—a clinician's approach to diagnosis and treatment.

Perit Dial Int 2005; 25(Suppl 4): S30–8.

Kaushik

, Punia

R.P.

, Mohan

, Attri

A.K.

Tuberculous abdominal cocoon—a report of 6 cases and review of the literature.

World J Emerg Surg 2006; 1: 18.

Lalloo

, Krishna

, Maharajh

Case report: abdominal cocoon associated with tuberculous pelvic inflammatory disease.

Br J Radiol 2002; 75: 174–6.

Spellberg

, Edwards

Jr. , Ibrahim

Novel perspectives on mucormycosis: pathophysiology, presentation and management.

Clin Microbiol Rev 2005; 18: 556–69.

Roden

M.M.

, Zaoutis

T.E.

, Buchanan

W.L.

, Knudsen

T.A.

, Sarkisova

T.A.

, Schaufele

R.L.

Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Clin Infect Dis 2005; 41: 634–53.

Boelaert

J.R.

, Fenves

A.Z.

, Coburn

J.W.

Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry.

Am J Kidney Dis 1991; 18: 660–7.

Sedlacek

, Cotter

J.G.

, Suriawinata

A.A.

, Kaneko

T.M.

, Zuckerman

R.A.

, Parsonnet

Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B.

Am J Kidney Dis 2008; 51: 302–6.

Mohindra

, Mohindra

, Gupta

, Bakshi

, Gupta

S.K.

Rhinocerebral mucormycosis: the disease spectrum in 27 patients.

Mycoses 2007; 50: 290–6.